- Category
- Small (2023-24)
- Udyam number
- UDYAM-KL-09-0007529

Orient Drugs Private Limited
About Orient Drugs Private Limited
Data last updated:
Orient Drugs Private Limited is a private limited company based in Malappuram, Kerala, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 14 March 1997 and has been in existence for over 29 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U24231KL1997PTC011301. Its GSTIN is 32AAACO2826R1Z8 (Kerala).
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹2 Cr. It is led by directors including Abdu Avulan (Managing Director) and Favas Avulan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at 2/254 Orient Tower Vadakkemanna Kodur P.O, Malappuram, Kerala, India – 676504.
As per the financials filed for FY 2026, the company reported a revenue of ₹8.16 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹2.97 Lakh (net margin 0.4%) and EBITDA of ₹4.54 Lakh (EBITDA margin 0.6%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 8% over five years.
As per MCA filings, the company has satisfied charges of ₹1.15 Cr on record.
Orient Drugs Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-KL-09-0007529). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Orient Drugs
Contact details
Orient Drugs Private Limited's registered office is in Malappuram, Kerala. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address2/254 Orient Tower Vadakkemanna Kodur P.O, Malappuram, Kerala, India – 676504
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Orient Drugs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Orient Drugs is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Orient Drugs Private Limited, buy the company report.
Financials of Orient Drugs Private Limited
FY 2026 filings availableOrient Drugs Private Limited reported revenue of ₹8.16 Cr (up 3% YoY) for FY 2026.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 8% over five years, including 3% growth in the latest year. EBITDA fell 80% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹8.16 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.54 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.97 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.6% | ||||
| Net Profit Margin | 0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Orient Drugs Private Limited, buy the company report.
Board of directors of Orient Drugs Private Limited
Orient Drugs has 9 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Favas Avulan | Director | 26 Dec 2013 | 12 Years 10 Months | Current |
| Fathima Sheikmoossa Avulan | Director | 04 Mar 2016 | 10 Years 8 Months | Current |
| Jameela Konndla Badiuzzaman | Director | 01 Sep 1997 | 29 Years 2 Months | Current |
| Mumtaz Pothaparambath | Director | 01 Sep 1997 | 29 Years 2 Months | Current |
| Zubairali Valiyathodi | Director | 04 Mar 2016 | 10 Years 8 Months | Current |
| Naseer Kalappaden | Director | 14 Mar 1997 | 29 Years 8 Months | Current |
Auditor
Orient Drugs Private Limited is audited by C. SESHADRI NADAN for the financial year 2026.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| C. SESHADRI NADAN | FY 2026 | 027440 |
Shareholding
The shareholding of Orient Drugs Private Limited is on record for 5 financial years, the latest being FY 2026, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Orient Drugs Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 Oct 2007 | 10075652 | South Indian Bank Limited | ₹90 Lakh | Satisfied | |
| 02 Aug 2004 | 90020010 | The Federal Bank Ltd. | ₹25 Lakh | Satisfied |
To see the full charge records of Orient Drugs Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Orient Drugs Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Orient Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Orient Drugs has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AAACO2826R1Z8 | Kerala | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Orient Drugs Private Limited, buy the company report.
Recent activity
Orient Drugs Private Limited has 17 board changes on record since 1997: 9 appointments and 8 cessations. The latest: Shibibiyya Mecheri ceased to be Additional Director on 18 Sep 2024.
14 earlier events are in the company report.
Frequently asked questions
Orient Drugs is an active private limited company based in Malappuram, Kerala, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 14 March 1997 (29+ years old) and is registered under CIN U24231KL1997PTC011301.
Orient Drugs has 9 current directors:
- Abdu Avulan - Managing Director
- Favas Avulan - Director
- Fathima Sheikmoossa Avulan - Director
- Jameela Konndla Badiuzzaman - Director
- Mumtaz Pothaparambath - Director
- Zubairali Valiyathodi - Director
- Naseer Kalappaden - Director
- Ummer Thekkepath - Director
- Shibibiyya Mecheri - Director
The latest financial statements of Orient Drugs on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Orient Drugs is 32AAACO2826R1Z8, registered in Kerala.
The CIN (Corporate Identification Number) of Orient Drugs is U24231KL1997PTC011301. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Orient Drugs was incorporated on 14 March 1997, making it 29+ years old. It is registered with the Registrar of Companies, Ernakulam.
Shibibiyya Mecheri ceased to be Additional Director on 18 Sep 2024. Achamban Thayummu ceased to be Director on 04 Apr 2022. Shibibiyya Mecheri was appointed as Director on 04 Apr 2022. Orient Drugs has 17 board changes on record in total.
Yes, Orient Drugs is registered as a small enterprise under Udyam registration (number: UDYAM-KL-09-0007529).
The registered office of Orient Drugs is at 2254 Orient Tower Vadakkemanna Kodur P.O, Malappuram, Kerala, India – 676504.
Orient Drugs operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

